This study investigated the potential antioxidant and antidiabetic activity of Monascus-fermented ginger extract (MGE). Gingers was fermented with Monascus pilosus KCCM 60084 for 2 weeks at 30°C and extracted with 95% ethanol. The antioxidant activity of the ethyl acetate fraction of the MGE was measured through DPPH, ABTS, and FRAP. The antioxidant activity of MGE increased 2.36 to 3.76-fold compared with those of raw ginger extracts (CGE) (P<0.05). The ethyl acetate fraction of MGE had a higher potential to inhibit the key digestive enzymes linked to type 2 diabetes (α-amylase, α-glucosidase) as compared to CGE (P<0.05). The IC50 for the α-amylase inhibitory activity (3.40±0.88 mg/mL) of MGE showed a higher potency than acarbose (7.01±0.23 mg/mL), which is currently used as a diabetes treatment. Moreover, the ethyl acetate fraction of MGE increased the expression of glucose transporter type 4 (GLUT4), glucokinase (GCK), and AMP-activated protein kinase (AMPK) in HepG2 cells. These findings demonstrate that the ethyl acetate fraction of MGE significantly improved glucose uptake in HepG2 cells by activating both PI3K/Akt and AMPK phosphorylation pathways. Our results suggest that MGE show the potential to be developed as a antidiabetic nutraceuticals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.